47 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
1578483	36	Rationally designed"dipeptoid" analogues of CCK. A Free-Wilson/Fujita-Ban analysis of some alpha-methyltryptophan derivatives as CCK-B antagonists.	Parke-Davis Neuroscience Research Centre
2452253	1	Synthesis and biological activity of CCK26-33-related analogues modified in position 31.	University of Paris
3560164	14	Synthesis and binding affinities of analogues of cholecystokinin-(30-33) as probes for central nervous system cholecystokinin receptors.	TBA
11000005	16	Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.	James Black Foundation
9438020	67	Second generation"peptoid" CCK-B receptor antagonists: identification and development of N-(adamantyloxycarbonyl)-alpha-methyl-(R)-tryptophan derivative (CI-1015) with an improved pharmacokinetic profile.	Warner-Lambert
7684452	66	Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and"mixed" CCK-A/CCK-B antagonists.	Parke-Davis Neuroscience Research Centre
1573640	54	Amide bond replacements incorporated into CCK-B selective"dipeptoids".	Parke-Davis Neuroscience Research Center
1635058	50	Rationally designed"dipeptoid" analogues of CCK. Acid mimics of the potent and selective non-peptide CCK-B receptor antagonist CI-988.	Parke-Davis Neuroscience Research Centre
1671419	48	Rationally designed"dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties.	Parke-Davis Research Unit
11266174	51	Design of non-peptide CCK2 and NK1 peptidomimetics using 1-(2-nitrophenyl)thiosemicarbazide as a novel common scaffold.	Novartis Institute For Medical Sciences
10866391	10	The design and synthesis of the high efficacy, non-peptide CCK1 receptor agonist PD170292.	Ccipe-Faculte De Pharmacie
	66	Design and synthesis of a targeted set of aromatic amino acid derivatives for identification of new lead compounds	TBA
	10	Synthesis of novel iodinated radioligands with high affinity and selectivity for CCK-B/gastrin receptors	TBA
	27	The rational design and synthesis of non-peptide rhegnylogues of CCK-26-33 - a novel series of CCK-A selective ligands	TBA
	7	Synthesis of a potent and selective non-peptide CCK-B/gastrin receptor antagonist tritiated ligand.	TBA
	10	Cholecystokinin analogues: The ergopeptine alkaloids as models of the active conformation of CCK	TBA
	22	Design and synthesis of novel nonpeptide CCK-B receptor antagonists	TBA
	38	SAR study of the indole moiety of CI-988, a potent and selective CCK-B antagonist	TBA
	45	Synthesis and pharmacological evaluation of highly potent dual histamine H2 and gastrin receptor antagonists	TBA
	87	Design, synthesis, and pharmacological evaluation of dual histamine H2 and gastrin receptor antagonists	TBA
	40	Novel cholecystokinin receptor ligands: Oxopiperazines derived from Boc-CCK-4	TBA
	13	Alternative strategies towards the identification of chemical lead compounds by rational design	TBA
	23	Methionine replacements in biologically active peptides	TBA
	12	α-β-didehydrotryptophan as a surrogate for α-methyltryptophan in CCK ‘peptoids’ related to CI-988.	TBA
	24	Selective ligands for cholecystokinin receptor subtypes CCK-A and CCK-B within a single structural class	TBA
	24	Diphenylpyrazolidinone and benzodiazepine cholecystokinin antagonists: A case of convergent evolution in medicinal chemistry	TBA
	11	Diastereoselective synthesis of cyclopropyl phenylalanines and their incorporation into dipeptides	TBA
	34	Synthesis and sar study of novel CCK-B antagonists	TBA
	8	The use of a proline ring as a conformational restraint in CCK-B receptor “dipeptoids”.	TBA
	14	The synthesis and CCK receptor affinities of selected carboyxlic acid mimics of CI-988 - a potent and selective CCK-B antagonist	TBA
18614364	109	Discovery of imidazole carboxamides as potent and selective CCK1R agonists.	Merck Research Laboratories
9990454	26	Highly constrained dipeptoid analogues containing a type II' beta-turn mimic as novel and selective CCK-A receptor ligands.	Instituto De QuíMica MéDica (Csic)
9544204	100	Novel nonpeptide CCK-B antagonists: design and development of quinazolinone derivatives as potent, selective, and orally active CCK-B antagonists.	Parke-Davis Pharmaceutical Research
8411002	67	Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties.	University of Paris
16250638	46	Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists.	James Black Foundation
11000006	28	2,7-Dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a new template for the design of CCK(2) receptor antagonists.	James Black Foundation
8627604	38	Non-peptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic, heteroaromatic skeletons.	James Black Foundation
7473557	65	Improving the affinity and selectivity of a nonpeptide series of cholecystokinin-B/gastrin receptor antagonists based on the dibenzobicyclo[2.2.2]octane skeleton.	James Black Foundation
7966125	26	A new class of non-peptidic cholecystokinin-B/gastrin receptor antagonists based on dibenzobicyclo[2.2.2]octane.	James Black Foundation
2438407	14	Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.	TBA
2016728	43	Quinazolinone cholecystokinin-B receptor ligands.	Eli Lilly
1635055	7	Synthesis and X-ray crystallographic analysis of quinazolinone cholecystokinin/gastrin receptor ligands.	Eli Lilly